STE · 10-Q · 2026Q2 · Full report

Capital Return Program

STERIS plc · 2026-08-07 · Importance 58 · Surprise 42 · In source text

STERIS repurchased 0.5 million ordinary shares for $100.0 million during the first three months of fiscal 2027 under the share-repurchase program adopted by the Board on May 5, 2026. No repurchases occurred under the previous program during the first three months of fiscal 2026. The Company also acquired 0.1 million shares for $15.5 million in connection with share-based compensation programs, compared with $10.6 million in the prior-year period. Cash dividends paid increased to $61.4 million, or $0.63 per share, from $56.2 million, or $0.57 per share.

Key facts

• Repurchases of ordinary shares during the first three months of fiscal 2027: 0.5 million shares for aggregate purchase amount of $100.0 million (exclusive of fees); during the first three months of fiscal 2026, no repurchase activity under previous program. source
• Cash dividends paid to ordinary shareholders during the first three months of fiscal 2027: $61.4 million total, or $0.63 per outstanding share; during the first three months of fiscal 2026: $56.2 million total, or $0.57 per outstanding share. source
• During each of the first three month periods of fiscal 2027 and fiscal 2026, STERIS obtained 0.1 million ordinary shares in connection with share-based compensation award programs for aggregate amounts of $15.5 million (2027) and $10.6 million (2026), respectively. source
• Net cash used in financing activities included repurchases and dividends such that stock option and other equity transactions net proceeds were $1.3 million (2027) and $9.3 million (2026). source

Impact estimates